Cyclerion Therapeutics

KRSA · NASDAQ

$31.03−$0.38 (−1.21%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $31.41

KRSA analyst rating

BuyConsensus of 5 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy5
Hold0
Underperform0
Sell0

12-month price target · 2 analysts

Average $0.00 (−100.0% downside)

Low: $0.00
Now: $31.03
High: $0.00

Upgrades and downgrades

The latest rating actions, newest first

KRSA analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wedbush	Oct 5, 2026	Initiates	Outperform	$44.00	40%
Guggenheim	Sep 28, 2026	Initiates	Buy	$70.00	49%
Stifel	Sep 14, 2026	Initiates	Buy	$43.00	41%
TD Cowen	Sep 14, 2026	Initiates	Buy	—	49%
UBS	Sep 11, 2026	Initiates	Buy	$55.00	53%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.